The interaction of human cholinesterases with anticholinesterases used in the therapy of myasthenia gravis.
作者信息
Foldes F F, Smith J C
出版信息
Ann N Y Acad Sci. 1966 Jan 26;135(1):287-301. doi: 10.1111/j.1749-6632.1966.tb45477.x.
Abstract
摘要
相似文献
1
The interaction of human cholinesterases with anticholinesterases used in the therapy of myasthenia gravis.人类胆碱酯酶与用于重症肌无力治疗的抗胆碱酯酶之间的相互作用。
Ann N Y Acad Sci. 1966 Jan 26;135(1):287-301. doi: 10.1111/j.1749-6632.1966.tb45477.x.
2
[Current treatment of myasthenia gravis].[重症肌无力的当前治疗方法]
Rev Paul Med. 1965 Oct;67(4):231-42.
3
[Myasthenia gravis pseudoparalytica. Clinical picture, pathogenesis, therapy].[重症肌无力假性麻痹。临床表现、发病机制、治疗]
Med Klin. 1973 Jun 1;68(22):723-30.
4
Pharmacologic enhancement of neuromuscular transmission in myasthenia gravis.重症肌无力中神经肌肉传递的药理学增强
Clin Neuropharmacol. 1982;5(3):277-92. doi: 10.1097/00002826-198205030-00003.
5
[Therapy of myasthenia gravis in pregnancy].[妊娠期重症肌无力的治疗]
Minerva Ginecol. 1980 Jan-Feb;32(1-2):21-6.
6
[On the treatment of myasthenia].[论重症肌无力的治疗]
Rev Med Liege. 1968 Sep 15;23(18):552-7.
7
[Current therapy of myasthenia gravis. I. Specific symptomatic therapy].[重症肌无力的当前治疗。I. 特异性对症治疗]
Nervenarzt. 1972 Jul;43(7):341-4.
8
Treatment of myasthenia gravis.重症肌无力的治疗。
N Engl J Med. 1973 Jan 4;288(1):27-31. doi: 10.1056/NEJM197301042880107.
9
[Therapetic measures in myasthenia gravis].[重症肌无力的治疗措施]
Minerva Anestesiol. 1969 Aug;35(8):765-79.
10
[Therapy of pseudoparalytic myasthenia gravis].[假性麻痹性重症肌无力的治疗]
Dtsch Med Wochenschr. 1975 Oct 31;100(44):2283-4. doi: 10.1055/s-0028-1106536.
引用本文的文献
1
Plasma cholinesterase activity in newborns and infants.新生儿和婴儿的血浆胆碱酯酶活性
Can Anaesth Soc J. 1971 May;18(3):278-85. doi: 10.1007/BF03025463.
2
The inhibitory effect of esmolol on human plasmacholinesterase.艾司洛尔对人血浆胆碱酯酶的抑制作用。
Can Anaesth Soc J. 1986 May;33(3 Pt 1):332-5. doi: 10.1007/BF03010746.
3
Plasma cholinesterase activity in patients during therapy with dexamethasone or prednisone.地塞米松或泼尼松治疗期间患者的血浆胆碱酯酶活性。
Eur J Clin Pharmacol. 1989;36(3):253-7. doi: 10.1007/BF00558156.
4
Stereoselectivity of cholinesterase inhibition by galanthamine and tolerance in humans.加兰他敏对胆碱酯酶抑制作用的立体选择性及人体耐受性
Eur J Clin Pharmacol. 1990;39(6):603-5. doi: 10.1007/BF00316106.
5
Acetylcholinesterase activity and menstrual remissions in myasthenia gravis.重症肌无力中的乙酰胆碱酯酶活性与月经缓解情况
J Neurol Neurosurg Psychiatry. 1977 Nov;40(11):1060-5. doi: 10.1136/jnnp.40.11.1060.
Zotero 插件